The research and diagnostics startup, which has partnered with Swiss pharmaceutical giant Roche, is leveraging genomics to fill the gap in African data on cancer to generate better treatments.
Founded in the midst of the Covid-19 pandemic, the Ghanaian company Yemaachi Biotech is spearheading cancer research in Africa. Returning to Ghana in 2019, after obtaining a doctorate in microbiology and immunology in the United States (Northwestern University, Chicago), Yaw Bediako decided to try his hand at entrepreneurship.
Read the full article here: Jeune Afrique